NHS trial offers hope to skin cancer patients
Skin cancer patients are set to receive a potentially life-saving vaccine as part of an expansion of a groundbreaking NHS trial. The needle-free injection aims to boost the immune system, helping the body fight and remember cancer cells to prevent the disease from returning.
Prime Minister announces plans for health data research service
Patients diagnosed with advanced melanoma, the deadliest form of skin cancer causing 2,340 deaths annually in the UK, will be the first to receive the vaccine starting next month. This development follows the Prime Minister's announcement of a new health data research service to hasten the development of therapies and medicines.
Real-life success story of a trial participant
Paul Thomas, a grandfather from Hampshire, has seen significant tumor shrinkage since joining the trial last year. He expressed optimism for total cancer eradication and praised the trial for the progress he has witnessed.
Personalized medicine and tailored therapies
Cancer vaccines are an example of personalized medicine, tailoring treatment to patients' genetic makeup. Keir Starmer and Professor Peter Johnson have both praised the innovation, highlighting its potential to revolutionize cancer care and save lives.
Expanding access to disease-busting vaccines
The vaccine iSCIB1+, developed by Oxford-based Scancell, is the latest to be trialed under NHS England's Cancer Vaccine Launch Pad. By 2030, 10,000 patients in England are expected to benefit from this initiative.
Potential to transform cancer care and save lives
Minister of State for Health, Karin Smyth, emphasized the importance of advancements in skin cancer treatment, drawing from her personal experience with the disease. The new DNA vaccine targets specific biomarkers in melanoma tumors, triggering the immune system to seek out and destroy cancer cells.
Encouraging progress in the fight against melanoma
Melanoma Focus CEO, Susanna Daniels, hailed the progress in innovative treatments for deadly melanoma skin cancer. The use of vaccines in melanoma treatment represents an exciting development that could offer hope to eligible patients.
